Kirschbaum Marc, Adelmeijer Jelle, Alkozai Edris M, Porte Robert J, Lisman Ton
Surgical Research Laboratory, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Section of Hepatobiliairy Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
J Clin Transl Res. 2016 Aug 3;2(3):97-106. eCollection 2016 Nov 10.
Blood platelets have been shown to stimulate liver regeneration after partial hepatectomy in animal models and humans, but the molecular mechanisms involved are unclear. It has been proposed that growth factors and angiogenic molecules stored within platelets drive platelet-mediated liver regeneration, but little direct evidence in support of this mechanism is available. We assessed levels of relevant platelet-derived proteins (vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, platelet-derived growth factor, thrombospondin, and endostatin) in platelet-rich and platelet-poor plasma taken at various perioperative time points from patients undergoing a (extended) right partial hepatectomy ( = 17) or a pylorus-preserving pancreatico-duodenectomy ( = 10). In addition, we collected intraoperative samples from the efferent and afferent liver veins prior to and after completion of liver resection. Twenty-four healthy controls were included to establish reference ranges for the various tests. Although we demonstrate perioperative changes in platelet and plasma levels of the proteins assessed, the changes observed in patients undergoing partial hepatectomy largely mirror the changes observed in patients undergoing a pylorus-preserving pancreatico-duodenectomy. In addition, no change in the growth factor levels in platelet-rich plasma between afferent and efferent liver veins was observed. Thus, the absence of an intra- or postoperative consumption of platelet-derived proteins in patients undergoing partial hepatectomy argues against a role of release of these molecules in stimulation of liver regeneration. In depth knowledge of the mechanism underlying platelet-mediated liver regeneration may facilitate development of targeted therapeutic interventions for patients with failing liver regeneration, which for example may occur following a partial hepatectomy. Although the prevailing dogma is that platelet stimulate liver regeneration by release of growth factors stored within platelets, data in this manuscript argue against this mechanism and suggest other pathways to be responsible.
在动物模型和人类中,血小板已被证明可刺激部分肝切除术后的肝脏再生,但其中涉及的分子机制尚不清楚。有人提出,血小板中储存的生长因子和血管生成分子驱动血小板介导的肝脏再生,但几乎没有直接证据支持这一机制。我们评估了接受(扩大)右半肝切除术(n = 17)或保留幽门的胰十二指肠切除术(n = 10)的患者在围手术期不同时间点采集的富血小板血浆和贫血小板血浆中相关血小板衍生蛋白(血管内皮生长因子、肝细胞生长因子、成纤维细胞生长因子、血小板衍生生长因子、血小板反应蛋白和内皮抑素)的水平。此外,我们在肝切除完成前后从肝静脉的流出支和流入支采集了术中样本。纳入24名健康对照者以建立各项检测的参考范围。虽然我们证明了所评估蛋白质的血小板和血浆水平在围手术期有变化,但在接受部分肝切除术的患者中观察到的变化在很大程度上反映了在接受保留幽门的胰十二指肠切除术的患者中观察到的变化。此外,未观察到肝静脉流入支和流出支之间富血小板血浆中生长因子水平的变化。因此,接受部分肝切除术的患者在术中或术后不存在血小板衍生蛋白的消耗,这表明这些分子的释放对刺激肝脏再生不起作用。深入了解血小板介导的肝脏再生的潜在机制可能有助于为肝脏再生失败的患者开发靶向治疗干预措施,例如部分肝切除术后可能出现的肝脏再生失败。虽然普遍的观点是血小板通过释放储存在血小板内的生长因子来刺激肝脏再生,但本手稿中的数据反对这一机制,并表明其他途径才是原因。